Unknown

Dataset Information

0

Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia.


ABSTRACT:

SUBMITTER: Ravandi F 

PROVIDER: S-EPMC6278965 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4803139 | biostudies-literature
| S-EPMC4822512 | biostudies-literature
| S-EPMC8580622 | biostudies-literature
| S-EPMC9327534 | biostudies-literature
| S-EPMC7289527 | biostudies-literature
| S-EPMC8171365 | biostudies-literature
| S-EPMC6167965 | biostudies-literature
| S-EPMC6119144 | biostudies-literature
| S-EPMC4110914 | biostudies-literature
| S-EPMC3023007 | biostudies-literature